These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29620167)

  • 1. Decreased expression of SFRP2 promotes development of the pituitary corticotroph adenoma by upregulating Wnt signaling.
    Ren J; Jian F; Jiang H; Sun Y; Pan S; Gu C; Chen X; Wang W; Ning G; Bian L; Sun Q
    Int J Oncol; 2018 Jun; 52(6):1934-1946. PubMed ID: 29620167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.
    Seltzer J; Ashton CE; Scotton TC; Pangal D; Carmichael JD; Zada G
    Neurosurg Focus; 2015 Feb; 38(2):E17. PubMed ID: 25639319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.
    Jian F; Chen Y; Ning G; Fu W; Tang H; Chen X; Zhao Y; Zheng L; Pan S; Wang W; Bian L; Sun Q
    Oncotarget; 2016 Feb; 7(8):9175-87. PubMed ID: 26824322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.
    Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M
    Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids.
    Gatto F; Feelders RA; van der Pas R; van Koetsveld P; Bruzzone E; Arvigo M; Dogan F; Lamberts S; Ferone D; Hofland L
    J Endocrinol; 2020 Apr; 245(1):101-113. PubMed ID: 32027601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles.
    Cassarino MF; Ambrogio AG; Cassarino A; Terreni MR; Gentilini D; Sesta A; Cavagnini F; Losa M; Pecori Giraldi F
    J Neuroendocrinol; 2018 Sep; 30(9):e12628. PubMed ID: 29920815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
    Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the ERK pathway for the treatment of Cushing's disease.
    Zhang D; Bergsneider M; Wang MB; Heaney AP
    Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Oxytocin on Cell Proliferation in a Corticotroph Adenoma Cell Line.
    Lim JS; Eom YW; Lee ES; Kwon HJ; Kwon JY; Choi J; Chung CH; Jo YS; Lee EJ
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):302-313. PubMed ID: 31565883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ.
    Gentilin E; Tagliati F; Filieri C; Molè D; Minoia M; Rosaria Ambrosio M; Degli Uberti EC; Zatelli MC
    Endocrinology; 2013 May; 154(5):1690-700. PubMed ID: 23525216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
    Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
    Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSP-1 is downregulated and inversely correlates with miR-449c expression in Cushing's disease.
    Ren J; Gu C; Yang Y; Xue J; Sun Y; Jian F; Chen D; Bian L; Sun Q
    J Cell Mol Med; 2019 Jun; 23(6):4097-4110. PubMed ID: 31016850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SFRP2 suppresses trophoblast cell migration by inhibiting the Wnt/β‑catenin pathway.
    Lan R; Yu Y; Song J; Xue M; Gong H
    Mol Med Rep; 2024 Apr; 29(4):. PubMed ID: 38426532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced levels of E-cadherin correlate with progression of corticotroph pituitary tumours.
    Evang JA; Berg JP; Casar-Borota O; Lekva T; Kringen MK; Ramm-Pettersen J; Bollerslev J
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):811-8. PubMed ID: 21595730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells.
    Yurekli BS; Karaca B; Kisim A; Bozkurt E; Atmaca H; Cetinkalp S; Ozgen G; Yilmaz C; Uzunoglu S; Uslu R; Saygili F
    J Endocrinol Invest; 2018 Feb; 41(2):233-240. PubMed ID: 28730425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma.
    Tateno T; Izumiyama H; Doi M; Akashi T; Ohno K; Hirata Y
    Endocr J; 2007 Dec; 54(5):777-82. PubMed ID: 17917309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC2 expression and variable number of repeats in exon 1 of the HDAC2 gene in corticotroph adenomas.
    Evang JA; Borota OC; Melum E; Holm R; Ramm-Pettersen J; Bollerslev J; Berg JP
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):229-35. PubMed ID: 20346000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted frizzled‑related protein 2 is epigenetically silenced and functions as a tumor suppressor in oral squamous cell carcinoma.
    Xiao C; Wang L; Zhu L; Zhang C; Zhou J
    Mol Med Rep; 2014 Nov; 10(5):2293-8. PubMed ID: 25189527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted frizzled-related protein 2 (SFRP2) expression promotes lesion proliferation via canonical WNT signaling and indicates lesion borders in extraovarian endometriosis.
    Heinosalo T; Gabriel M; Kallio L; Adhikari P; Huhtinen K; Laajala TD; Kaikkonen E; Mehmood A; Suvitie P; Kujari H; Aittokallio T; Perheentupa A; Poutanen M
    Hum Reprod; 2018 May; 33(5):817-831. PubMed ID: 29462326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.